首页|期刊导航|中华医学杂志(英文版)|Tenofovir vs.entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
中华医学杂志(英文版)2022,Vol.135Issue(3):301-308,8.DOI:10.1097/CM9.0000000000001864
Tenofovir vs.entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
Tenofovir vs.entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
摘要
关键词
Hepatocellular carcinoma/Hepatitis B virus/Antiviral drugs/Recurrence/HepatectomyKey words
Hepatocellular carcinoma/Hepatitis B virus/Antiviral drugs/Recurrence/Hepatectomy引用本文复制引用
Junyi Shen,Weili Qi,Junlong Dai,Shusheng Leng,Kangyi Jiang,Yu Zhang,Shun Ran,Chuan Li,Tianfu Wen..Tenofovir vs.entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy[J].中华医学杂志(英文版),2022,135(3):301-308,8.基金项目
This study was supported by grants from the National Natural Science Foundation of China (No.82070625,No.81900576),the Science and Technology Project of Chengdu (No.2019-YF05-00302-SN),and the Post-Doctor Research Project,West China Hospital,Sichuan University (No.2020HXBH069). (No.82070625,No.81900576)